Skip to Main Content

Alpha Tau Medical Ltd. Ordinary Shares

DRTS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
DRTS Income Statement
DRTS Balance Sheet
DRTS Cash Flow

Recent trades of DRTS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
DRTS Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
DRTS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
DRTS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by DRTS's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Radiotherapy seeds and applicators Nov. 12, 2024
  • Patent Title: Diffusing alpha-emitter radiation therapy for melanoma Sep. 03, 2024
  • Patent Title: Diffusing alpha-emitter radiation therapy for colorectal cancer Sep. 03, 2024
  • Patent Title: Diffusing alpha-emitter radiation therapy for glioblastoma Sep. 03, 2024
  • Patent Title: Diffusing alpha-emitter radiation therapy for pancreatic cancer Aug. 27, 2024
  • Patent Title: Activity levels for diffusing alpha-emitter radiation therapy Aug. 27, 2024
  • Patent Title: Radiotherapy applicator with perpendicular or angled radial dispensing Aug. 27, 2024
  • Patent Title: Diffusing alpha-emitter radiation therapy for breast cancer Aug. 20, 2024
  • Patent Title: Diffusing alpha-emitter radiation therapy for squamous cell carcinoma Jul. 23, 2024
  • Patent Title: Radiotherapy applicator Jul. 02, 2024
  • Patent Title: Controlled release of radionuclides Apr. 30, 2024
  • Patent Title: Diffusing alpha-emitter radiation therapy for prostate cancer Apr. 23, 2024
  • Patent Title: Radiotherapy template assembly Jan. 16, 2024
  • Patent Title: Diffusing alpha-emitter radiation therapy with enhanced beta treatment Jan. 02, 2024
  • Patent Title: Treatment planning for alpha particle radiotherapy Jun. 06, 2023
  • Patent Title: Treatment planning for alpha particle radiotherapy Jun. 06, 2023
  • Patent Title: Polymer coatings for brachytherapy devices Dec. 20, 2022
  • Patent Title: Method and device for radiotherapy Aug. 28, 2018
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of DRTS in WallStreetBets Daily Discussion

DRTS News

Recent insights relating to DRTS

CNBC Recommendations

Recent picks made for DRTS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in DRTS

DRTS Top Shareholders
Shareholder
Shares Held
DRTS Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

DRTS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view DRTS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top